tradingkey.logo
tradingkey.logo
Search

Charles River Laboratories International Inc

CRL
Add to Watchlist
186.530USD
+4.970+2.74%
Close 06/23, 16:00ETQuotes delayed by 15 min
8.99BMarket Cap
LossP/E TTM

TradingKey Stock Score of Charles River Laboratories International Inc

Currency: USD Updated: 2026-06-23

Key Insights

Charles River Laboratories International Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 389 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 216.82.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Charles River Laboratories International Inc's Score

Industry at a Glance

Industry Ranking
15 / 389
Overall Ranking
53 / 4573
Industry
Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

42°C

Very Low
Very High
Positive

Charles River Laboratories International Inc Highlights

StrengthsRisks
Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD .
Fairly Valued
The company’s latest PE is -50.19, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 56.13M shares, decreasing 12.43% quarter-over-quarter.
Held by John Rogers
Star Investor John Rogers holds 1.51M shares of this stock.

Analyst Rating

Based on 19 analysts
Buy
Current Rating
216.820
Target Price
+19.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

How does TradingKey generate the Stock Score of Charles River Laboratories International Inc?

The TradingKey Stock Score provides a comprehensive assessment of Charles River Laboratories International Inc based on 34 indicators derived from over 100 underlying data points.
These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Charles River Laboratories International Inc’s performance and outlook.

How do we generate the financial health score of Charles River Laboratories International Inc?

To generate the financial health score of Charles River Laboratories International Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns.
By integrating these comprehensive data, the financial health score not only reflects Charles River Laboratories International Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Charles River Laboratories International Inc.

How do we generate the company valuation score of Charles River Laboratories International Inc?

To generate the company valuation score of Charles River Laboratories International Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Charles River Laboratories International Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value.
By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Charles River Laboratories International Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Charles River Laboratories International Inc.

How do we generate the earnings forecast score of Charles River Laboratories International Inc?

To calculate the earnings forecast score of Charles River Laboratories International Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:
Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.
Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.
By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.
Comparing these indicators against peers provides context for the stock’s performance and helps anchor more realistic expectations.
These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Charles River Laboratories International Inc’s future.

How do we generate the price momentum score of Charles River Laboratories International Inc?

When generating the price momentum score for Charles River Laboratories International Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.
Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.
This comprehensive approach can reflect market sentiment and enable rational forecasts of Charles River Laboratories International Inc’s prices. A higher score indicates a more stable short-term price trend for Charles River Laboratories International Inc.

How do we generate the institutional confidence score of Charles River Laboratories International Inc?

To generate the institutional confidence score of Charles River Laboratories International Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Charles River Laboratories International Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Charles River Laboratories International Inc.

How do we generate the risk management score of Charles River Laboratories International Inc?

To assess the risk management score of Charles River Laboratories International Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.
The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.
These indicators together provide a multi-dimensional understanding of Charles River Laboratories International Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Charles River Laboratories International Inc.
KeyAI